105 related articles for article (PubMed ID: 8840972)
1. Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines.
Wang S; Rowe M; Lundgren E
Cancer Res; 1996 Oct; 56(20):4610-3. PubMed ID: 8840972
[TBL] [Abstract][Full Text] [Related]
2. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest.
Okan I; Wang Y; Chen F; Hu LF; Imreh S; Klein G; Wiman KG
Oncogene; 1995 Sep; 11(6):1027-31. PubMed ID: 7566960
[TBL] [Abstract][Full Text] [Related]
3. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
[TBL] [Abstract][Full Text] [Related]
4. Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes.
Lømo J; Smeland EB; Krajewski S; Reed JC; Blomhoff HK
Cancer Res; 1996 Jan; 56(1):40-3. PubMed ID: 8548771
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody.
Piché A; Kasono K; Johanning F; Curiel TJ; Curiel DT
Gene Ther; 1998 Sep; 5(9):1171-9. PubMed ID: 9930317
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
Sheu LF; Chen A; Wei YH; Ho KC; Cheng JY; Meng CL; Lee WH
Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524
[TBL] [Abstract][Full Text] [Related]
7. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
10. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
Röth A; Pfaff P; Lange W; Finke J
Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
[TBL] [Abstract][Full Text] [Related]
11. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
12. Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by bcl-2.
Schrantz N; Blanchard DA; Mitenne F; Auffredou MT; Vazquez A; Leca G
Cell Death Differ; 1999 May; 6(5):445-53. PubMed ID: 10381635
[TBL] [Abstract][Full Text] [Related]
13. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
14. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
16. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes.
Masciarelli S; Mattioli B; Galletti R; Samoggia P; Chichiarelli S; Mearini G; Mattia E
Oncogene; 2002 Jun; 21(26):4166-70. PubMed ID: 12037673
[TBL] [Abstract][Full Text] [Related]
17. Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation.
Kawanishi M
Virology; 1997 Feb; 228(2):244-50. PubMed ID: 9123831
[TBL] [Abstract][Full Text] [Related]
18. The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy.
Lee DY; Sugden B
Oncogene; 2008 May; 27(20):2833-42. PubMed ID: 18037963
[TBL] [Abstract][Full Text] [Related]
19. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
20. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
Gojo I; Zhang B; Fenton RG
Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]